Having trouble accessing articles? Reset your cache.

Regulus sets IPO range

Regulus Therapeutics Inc. (San Diego, Calif.) amended its IPO and now plans to sell

Read the full 143 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE